⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Apimeds Pharmaceuticals US, Inc.

$3.87
+0.13 (+3.48%)

Market Capitalization:

$5.84M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Apimeds Pharmaceuticals US Market Segments

Regular Trading Hours

+0.00(+0.00%)
Open$3.87
Close$3.87
Low$3.87
Low Change0.00 (0.00%)
High$3.87
High Change+0.00 (+0.00%)
Range$0.00
Volume105
Dollar Volume$406.35

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$3.88
Close$3.88
Low$3.88
Low Change0.00 (0.00%)
High$3.88
High Change+0.00 (+0.00%)
Range$0.00
Volume159
Dollar Volume$616.92

Regular Trading Hours Yesterday

-0.35(-8.56%)
Open$4.09
Close$3.74
Low$3.73
Low Change-0.36 (-8.80%)
High$4.09
High Change+0.00 (+0.00%)
Range$0.36
Volume5.59K
Dollar Volume$20.91K

Premarket Yesterday

-0.20(-4.98%)
Open$4.02
Close$3.82
Low$3.82
Low Change-0.20 (-4.98%)
High$4.19
High Change+0.17 (+4.23%)
Range$0.37
Volume700
Dollar Volume$2.67K

Apimeds Pharmaceuticals US News

There is no current news for this stock at the moment.

Apimeds Pharmaceuticals US Top Trades

Apimeds Pharmaceuticals US's top trade so far today returned +0.00%, while the top short trade returned 0.00%.

Apimeds Pharmaceuticals US Moving Averages

5 Day Moving Average (SMA5)$4.13
10 Day Moving Average (SMA10)$4.29
20 Day Moving Average (SMA20)$4.44
50 Day Moving Average (SMA50)$2.94
100 Day Moving Average (SMA100)$2.24
200 Day Moving Average (SMA200)$2.08

Apimeds Pharmaceuticals US Statistics

Average Volume (30 Days)142.66K
P/E Ratio (Current)-.10
EPS (Current)-$38.55
Dividend Yield0.00%
Free Cash Flow-$13.33M
Cash Ratio0.01
Current Ratio0.51
Quick Ratio0.51
Debt to Equity0.08
Enterprise Value$14.47M
EV to EBITDA-0.53
EV to Sales
Price to Book0.05
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.46%
Return on Equity-0.55%

Apimeds Pharmaceuticals US Stock Splits

There has been 1 stock split for Apimeds Pharmaceuticals US (APUS). The reverse stock split occured on March 26, 2026 and reduced the outstanding shares at a ratio of 10:1.

DateTypeRatio
Mar 26, 2026Reverse10:1

Apimeds Pharmaceuticals US Dividends

There have been no dividends for Apimeds Pharmaceuticals US (APUS).